Showing results (161-170 of 279) with videos related to

Sort By:
Pageof 28
The American Journal of Pathology|April 16, 2013
Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signalingOliver Frings, Martin Augsten, Nicholas P Tobin, et al.
BMC Cancer|December 1, 2017
Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profilingGovindasamy-Muralidharan Karthik, Mattias Rantalainen, Gustav Stålhammar, et al.
BMC Medicine|August 6, 2026
Assessment of Trophoblast cell surface antigen 2 (Trop-2) expression and its clinical significance in breast cancer: a multi-level analysis of protein and gene expressionMaria Angeliki Toli, Michail Sarafidis, Panagiotis Filis, et al.
Breast Cancer Research : BCR|July 19, 2006
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patientsStefano Calza, Per Hall, Gert Auer, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2005
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalLance D Miller, Johanna Smeds, Joshy George, et al.
JNCI Cancer Spectrum|January 14, 2021
Long-Term Prognostication for 20 114 Women With Small and Node-Negative Breast Cancer (T1abN0)David Jaraj, Jonas Höijer, Linnea Widman, et al.
Acta Oncologica (Stockholm, Sweden)|February 9, 2011
Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1Per Edlund, Johan Ahlgren, Karsten Bjerre, et al.
The Oncologist|December 2, 2017
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple MyelomaKyriaki Tzogani, Paula van Hennik, Ita Walsh, et al.
Cancer Research|July 20, 2006
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcomeJonna Frasor, Edmund C Chang, Barry Komm, et al.
Acta Oncologica (Stockholm, Sweden)|October 5, 2019
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancerAntroula Papakonstantinou, Elham Hedayati, Mats Hellström, et al.
Pageof 28